Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Joby Aviation Insider Sergey Novikov Sells $17.6K of Stock
Sergey Novikov sold 2,965 shares of Joby Aviation, Inc. at $5.95 a share, worth $17.6K in total on Oct 2, 2026. Shares held after the trade: 48,681 (-5.7%).
AbbVie provided a preliminary update for Q3 2026, noting that results will include $216 million in acquired IPR&D and milestones expense, which negatively impacts EPS by $0.11. Consequently, the company updated its full-year 2026 adjusted diluted EPS guidance to a range of $13.76 - $13.96 and its Q3 guidance to $3.73 - $3.77.
Gregory Bowles, Chief Policy Officer, sold 7,663 shares of Joby Aviation, Inc. at $5.95 a share, worth $45.6K in total on Oct 2, 2026. Shares held after the trade: 199,006 (-3.7%).
Joby Aviation CFO Rodrigo Brumana Sells $15.5K of Stock
Rodrigo Brumana, CFO, sold 2,601 shares of Joby Aviation, Inc. at $5.95 a share, worth $15.5K in total on Oct 2, 2026. Shares held after the trade: 113,275 (-2.2%).
Joby Aviation Insider Kate DeHoff Sells $57K of Stock
Kate DeHoff sold 9,575 shares of Joby Aviation, Inc. at $5.95 a share, worth $57K in total on Oct 2, 2026. Shares held after the trade: 189,178 (-4.8%).
Joby Aviation President of Operations Bonny W. Simi Sells $64.8K of Stock
Bonny W. Simi, President of Operations, sold 10,890 shares of Joby Aviation, Inc. at $5.95 a share, worth $64.8K in total on Oct 2, 2026. Shares held after the trade: 241,923 (-4.3%).
Castle Biosciences COO Kristen M. Oelschlager Sells $149K of Stock
Kristen M. Oelschlager, COO, sold 4,153 shares of Castle Biosciences Inc at $35.75 to $36.38 a share (average $35.95) in 2 transactions, worth $149K in total on Oct 1, 2026. Shares held after the trade: 13,356 (-9.2%).
Neptune Insurance Holdings President & Chief Risk Officer Matthew Paul Duffy Sells $1.1M of Stock
Matthew Paul Duffy, President & Chief Risk Officer, sold 39,737 shares of Neptune Insurance Holdings Inc. at $27.65 to $28.48 a share (average $27.67) in 2 transactions, worth $1.1M in total on Oct 2, 2026. Shares held after the trade: 2,005,631 (-0.1%).
Silver Bow Mining Corp. granted 3,648 restricted stock units (RSUs) to Travis Naugle under the company's long-term incentive plan. The awards will vest upon a change in control, a sale of the majority of assets, or Mr. Naugle's departure from the Board.
Lucid Group announced its Q3 2026 production and delivery totals, producing 2,954 vehicles and delivering 3,806 vehicles. The company is executing an operating reset to reduce inventory and align production with demand, targeting $1.4 billion in cash flow improvements for 2026. A formal earnings call to discuss full financial results is scheduled for November 9, 2026.
Serve Robotics Inc. updated its corporate investor presentation to include preliminary unaudited management estimates regarding its cost of revenue for the fiscal year ending December 31, 2026. The presentation highlights the company's commercial Level 4 autonomous robot fleets and its diversified revenue streams across delivery, healthcare, and advertising.
Neostellar Capital Corp. provided a preliminary update for the third quarter ended September 30, 2026, estimating its Net Asset Value (NAV) to be between $12.25 and $12.75 per share. The company also detailed portfolio activity, including the exercise of warrants in Shogun Enterprises and exits from several positions including Learneo, Inc. and GrabAGun Digital Holdings.
Iron Mountain EVP, Chief Commercial Officer Greg W. McIntosh Sells $554K of Stock
Greg W. McIntosh, EVP, Chief Commercial Officer, sold 5,000 shares of Iron Mountain Inc at $110.72 a share, worth $554K in total on Oct 1, 2026. Shares held after the trade: 70,634 (-6.6%).
OFA Group announced that Ernest Yeung resigned as Chief Financial Officer for personal reasons, effective September 30, 2026. The company appointed Eugene M. Johnston as the new CFO, effective October 1, 2026, under a two-year employment agreement providing a $150,000 base salary and an initial grant of 60,000 stock options.
Aimei Health Technology Co Debt Financing Update with Aimei Investment Ltd
Aimei Health Technology Co., Ltd issued an unsecured promissory note for $34,330.96 to Aimei Investment Ltd to fund a deposit into its trust account. This payment extends the company's deadline to complete its initial business combination with United Hydrogen from October 6, 2026, to November 6, 2026.
Valuence Merger Corp. I has extended its deadline to complete an initial business combination from October 3, 2026, to November 3, 2026. This represents the sixth of ten available one-month extensions, and the company deposited $13,897.14 into its trust account to facilitate the move.
Twist Bioscience CFO Adam Laponis Sells $1.52M of Stock
Adam Laponis, CFO, sold 8,057 shares of Twist Bioscience Corp at $188.88 a share, worth $1.52M in total on Oct 2, 2026. Shares held after the trade: 100,576 (-7.4%).
Aflac Insider Japan Post Holdings Co. Ltd. Sells $1.32M of Stock
Japan Post Holdings Co. Ltd. sold 11,900 shares of Aflac Inc at $111.18 to $111.74 a share (average $111.18) in 2 transactions, worth $1.32M in total on Oct 1, 2026. Shares held after the trade: 50,433,390 (-0.0%).
Twist Bioscience CEO Emily M. Leproust Sells $8.77M of Stock
Emily M. Leproust, CEO, sold 46,391 shares of Twist Bioscience Corp at $188.88 to $200.00 a share (average $189.04) in 2 transactions, worth $8.77M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 567,308 (-7.5%).
Twist Bioscience President and COO Patrick John Finn Sells $4.86M of Stock
Patrick John Finn, President and COO, sold 25,714 shares of Twist Bioscience Corp at $188.88 a share, worth $4.86M in total on Oct 2, 2026. Shares held after the trade: 185,088 (-12.2%).
Twist Bioscience SVP of Human Resources Paula Green Sells $1.91M of Stock
Paula Green, SVP of Human Resources, sold 10,088 shares of Twist Bioscience Corp at $188.88 a share, worth $1.91M in total on Oct 2, 2026. Shares held after the trade: 106,632 (-8.6%).
Twist Bioscience Insider Dennis Cho Sells $1.8M of Stock
Dennis Cho sold 9,514 shares of Twist Bioscience Corp at $188.88 a share, worth $1.8M in total on Oct 2, 2026. Shares held after the trade: 63,789 (-13.0%).
Twist Bioscience CAO Robert F. Werner Sells $280K of Stock
Robert F. Werner, CAO, sold 1,482 shares of Twist Bioscience Corp at $188.88 a share, worth $280K in total on Oct 2, 2026. Shares held after the trade: 42,917 (-3.3%).
Nuscale Power CFO Robert Ramsey Hamady Sells $158K of Stock
Robert Ramsey Hamady, CFO, sold 20,000 shares of Nuscale Power Corp at $7.89 a share, worth $158K in total on Oct 1, 2026. Shares held after the trade: 144,235 (-12.2%).
X4 Pharmaceuticals CFO David Kirske Sells $33.7K of Stock
David Kirske, CFO, sold 11,767 shares of X4 Pharmaceuticals, Inc at $2.86 a share, worth $33.7K in total on Oct 1, 2026. Shares held after the trade: 155,983 (-7.0%).
Endovia Health Sciences announced that the FDA's Center for Veterinary Medicine determined its investigational drug CannEpil qualifies as a 'minor use' under the MUMS program for canine bone cancer pain. This designation allows the company to pursue a conditional approval pathway, which facilitates earlier market availability while additional effectiveness data is collected. The company is targeting a potential U.S. veterinary product launch in 2027.
Mark Lin, EVP and CFO, sold 967 shares of Semtech Corp at $178.87 a share, worth $173K in total on Oct 1, 2026. Shares held after the trade: 35,999 (-2.6%).
Peoples Bancorp M&A Deal with Capital Bancorp, Inc.
Peoples Bancorp Inc. (PEBO) has entered into a definitive agreement to acquire Rockville, Maryland-based Capital Bancorp, Inc. Management described the transaction as a transformational combination that adds scale and a differentiated set of businesses to the Peoples franchise.
Oklo Co-Founder, COO Caroline Cochran Sells $4.38M of Stock
Caroline Cochran, Co-Founder, COO, sold 120,000 shares of Oklo Inc. at $36.19 to $37.07 a share (average $36.51) in 4 transactions, worth $4.38M in total on Oct 1, 2026. Shares held after the trade: 476,483 (-4.0%).
Oklo Co-Founder, CEO Jacob DeWitte Sells $4.38M of Stock
Jacob DeWitte, Co-Founder, CEO, sold 120,000 shares of Oklo Inc. at $36.19 to $37.07 a share (average $36.51) in 4 transactions, worth $4.38M in total on Oct 1, 2026. Shares held after the trade: 509,479 (-3.8%).